Dermatology
2 drugs are in development for Netherton Syndrome.
- Companies
- 1
- Clinical trials
- 6
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Netherton Syndrome pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 2/Phase 3(2)
| Drug | Company |
|---|---|
| qrx003 | Quoin Pharmaceuticals, Ltd. (QNRX) |
| qrx007 | Quoin Pharmaceuticals, Ltd. (QNRX) |
About this indication
Netherton Syndrome context
Dermatology·MeSH: Netherton Syndrome (D056770)
Also known as: Netherton Disease
Frequently asked questions
How many drugs are in development for Netherton Syndrome?
BioSniper tracks 2 drugs in development for Netherton Syndrome across 1 company.
How many clinical trials target Netherton Syndrome?
There are 6 clinical trials targeting Netherton Syndrome tracked by BioSniper.